Oncology Corporate Profile
Angimmune LLC is a new small biotech company founded by Dr. David Neville and two former members of his previous lab at the National Institutes of Health (NIH), Dr. Yuan-Yi Liu and Dr. Jung-Hee Woo. While at NIH these founders developed a unique immunotoxin technology. Angimmune has now licensed this technology from NIH.
Website: https://www.angimmune.com
Brand / Product | Class | Area of Study | Phase | Partnership |
---|---|---|---|---|
Resimmune® | A-dmDT390-bisFv immunotoxin | Cutaneous T-cell Lymphoma (CTCL) | I | |
Resimmune® | A-dmDT390-bisFv immunotoxin | Melanoma | I |
View additional information on product candidates here »